Endocrine News Podcast · Endocrine Society

ENP102: Insulin Delivery Systems (CME credit available)

September 17, 2025·32 min·3 clips

Half of type 1 diabetes diagnoses happen after age 25 — and many are initially told they have type 2.

The focus is type 1 diabetes. Aaron Lohr frames the conversation around insulin delivery systems and notes that the episode is supported by educational grants from Mankind and Insulet, with AMA PRA Category 1 credits and ABIM MOC points available for listeners who complete the required pre-test, listen on the Endocrine Society Center for Learning, and then finish the post-test and evaluation. Drs. Grazia Aleppo and Diana Isaacs join the program. Aleppo, a professor of medicine at Northwestern University Feinberg School of Medicine, and Isaacs, director of education and training in diabetes and technology at the Cleveland Clinic, bring a practical, expert-led perspective to the topic. The discussion covers inhaled insulin and spends a lot of time on automated insulin delivery systems, especially how the field has moved from tightly controlled trials into broad real-world use. The clinical side matters here. The guests talk through concerns such as insulin stacking and the hypoglycemia that can follow, while also explaining why newer data have become more convincing as more people use these systems outside studies. Real-world outcomes come up again and again. The conversation points to reports across Medicare, Medicaid, insurance groups, older patients, younger patients, and families of children with type 1 diabetes. Less hypoglycemia is one benefit. Reduced diabetes distress and more flexible dosing are also presented as major advantages, especially when parents and clinicians are trying to make daily management less burdensome. The episode does not treat technology as self-explanatory. Instead, it keeps returning to education, since the guests agree that many health care providers still need help keeping up with the pace of change across insulin delivery methods. One resource gets particular attention. Diabetes Wise, especially its section for health care professionals, is highlighted as a place where clinicians can review the available delivery methods. The tone stays instructional without feeling stiff. That makes the program useful for anyone who wants a clear explanation of what is changing in diabetes care and why those changes matter in practice. The credit workflow is also spelled out. Listeners who want credits and points are told to take the pre-test before listening, then complete the episode on the Endocrine Society Center for Learning, and finally finish the post-test and evaluation before claiming credit.

As heard by us

A clinical tour of insulin delivery that weighs device progress against the realities of everyday diabetes care.

This physician-led conversation stays centered on type 1 diabetes and insulin delivery systems, with Drs. Grazia Aleppo and Diana Isaacs moving through inhaled insulin, automated insulin delivery, and how these tools function in everyday care.

Read the full review in PlayNext →

Why you'd press play

You want a plainspoken update on insulin delivery systems that still respects the science.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Endocrine News Podcast